Joseph Adrian Tyndall, M. D.
Board Member
Axogen, Inc. (AXGN)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Joseph Adrian Tyndall, M. D.
Joseph Adrian Tyndall, M. D. is recorded as Board Member at Axogen, Inc. (AXGN). Axogen, Inc. reported in an 8-K filed October 31, 2022 that Joseph Adrian Tyndall, M. D. was appointed new director to fill the vacant directorship on the Board, effective December 13, 2022.
“On October 25 2022, the Company's Board appointed Joseph Adrian Tyndall, M. D. as a new director to fill the vacant directorship on the Board, effective December 13, 2022.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2022-12-13–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Axogen, Inc.
Other people whose current roles at this company are on record from its filings.
- Michael Dale CEO, Board Member
- Paul G. Thomas Chairman, Board Member
- Paul Thomas Chairman
- Lindsey Hartley CFO
- Brad Ottinger General Counsel
- Bradley Ottinger General Counsel
- Alan Levine Board Member
- Alan M. Levine Board Member
- Amy Wendell Board Member
- John H. Johnson Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.